# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Charlotte Brontë (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI025-SYN
- Date: 2026-01-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Eleanor Thwaite, MD
- Calendar frame: modern shifted

## Reason for visit

First prenatal visit at 7 weeks with nausea and vomiting for a week and early weight loss: dating ultrasound, prenatal tests, and a plan for the nausea. **S**

## Historical basis

- Charlotte Brontë was born on 21 April 1816 in Thornton, Yorkshire, the third of six children of Maria Branwell and her husband, an Anglican clergyman. **D**
- Jane Eyre was first published in 1847 under the pseudonym Currer Bell. **D**
- Her mother died on 15 September 1821, in the 39th year of her age, after a long and painful illness. **D**
- Her mother's illness may have been cancer; one reference work says uterine cancer. The cause is a later interpretation. **R**
- Her two elder sisters, Maria and Elizabeth, fell ill at the Clergy Daughters' School at Cowan Bridge and died at home in 1825, Maria on 6 May aged 11 and Elizabeth on 15 June aged 10; reference works give tuberculosis. **D**
- Her brother Branwell died on 24 September 1848, aged 31, of several conditions made worse by heavy drinking; tuberculosis is listed among them. **D**
- Her sisters Emily and Anne died of tuberculosis, Emily on 19 December 1848 aged 30 and Anne on 28 May 1849 aged 29. **D**
- On 29 June 1854 she married Arthur Bell Nicholls, her father's curate, at Haworth. **D**
- In late November 1854, after a long walk on the moors to a waterfall that ended in heavy rain, she began to shiver and had a bad lingering sore throat and cold that made her thin and weak. **D**
- Early in 1855, after a visit to Gawthorpe and a long walk over damp ground in thin shoes, she was attacked by "new sensations of perpetual nausea, and ever-recurring faintness"; a doctor who was called assigned a natural cause for her indisposition. **D**

10 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- Nausea most of the day for a week and vomiting three or four times a day; she can no longer face meals and has lost about a kilogram. **S**
- She is glad of the pregnancy but anxious about her age and about her own health, having lost her mother and her sisters young. **S**
- She asks whether she could carry tuberculosis, since it was in her household. **S**

## Strengths and supports

- Supports: her husband, a close friend from school days with whom she writes often, and the household's long-serving help **S**

## Medications and allergies

- Folic acid 0.4 mg oral tablet, one tablet by mouth daily (replacing an iron-containing prenatal vitamin while nausea is severe) **S**
- Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, two tablets by mouth at bedtime **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- November 1854: A bad lingering sore throat and cold after a long walk in heavy rain on the moors, which made her thin and weak **D** (CLM-0009)

## Procedures and immunizations

- 2026-01-13 to 2026-01-13: Transvaginal dating ultrasound: single live intrauterine pregnancy, crown-rump length 11 mm (7 weeks 1 day), cardiac activity present, no subchorionic hemorrhage, ovaries normal **S**
- 2026-01-13: Influenza vaccine, 2025-2026 season, given in pregnancy **S**
- 2019-05-14: Tdap vaccine **S**

## Family history

- mother: Died in 1821 in her 39th year after a long and painful illness, possibly cancer **R** (CLM-0003, CLM-0004)
- sister: Eldest sister: tuberculosis after illness at boarding school; died in 1825 aged 11 **D** (CLM-0005)
- sister: Second sister: tuberculosis after illness at boarding school; died in 1825 aged 10 **D** (CLM-0005)
- brother: Died in 1848 aged 31 of several conditions made worse by heavy drinking, with tuberculosis among them **D** (CLM-0006)
- sister: Tuberculosis; died in 1848 aged 30 **D** (CLM-0007)
- sister: Tuberculosis; died in 1849 aged 29 **D** (CLM-0007)

## Measurements

Hemoglobin: 12.8 g/dL; White blood cells: 8.4 10*3/uL; Platelets: 248 10*3/uL; Sodium: 137 mmol/L; Potassium: 3.9 mmol/L; Chloride: 102 mmol/L; Bicarbonate (total CO2): 24 mmol/L; BUN: 8 mg/dL; Creatinine: 0.52 mg/dL; Glucose: 76 mg/dL; Urine ketones: 15 mg/dL (high); Crown-rump length: 11 mm; PHQ-9: 5. All results are synthetic.

BP 104/66 mmHg; pulse 84 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 45.1 kg; BMI 19.5 kg/m². All vital signs are synthetic.

## Examination

Mental status: Small and slight, neatly dressed, quietly spoken and articulate; tired; mood "worn out, but glad"; anxious about carrying a first pregnancy at her age after losing her mother and sisters young; no thoughts of self-harm; PHQ-9 score 5. Functional status: Until a week ago she ran the household and wrote each morning; now she lies down most afternoons and has stopped writing; she keeps down small sips and dry crackers. Physical examination is intentionally limited. **S**

## Assessment

1. First pregnancy at 38 (elderly primigravida), single live intrauterine pregnancy dated by ultrasound at 7 weeks 1 day; status draft. **S**
2. Nausea and vomiting of pregnancy, moderate (PUQE-24 score 10), with early weight loss, under evaluation for hyperemesis gravidarum; status draft. **S**

## Plan

- First prenatal visit: dating ultrasound; blood count, blood group and antibody screen, rubella immunity, hepatitis B surface antigen, HIV, syphilis, and hepatitis C tests; urine culture; metabolic panel and urinalysis because of vomiting; influenza vaccine; folic acid 0.4 mg daily in place of the iron-containing prenatal vitamin while nausea lasts. Guideline: USPSTF A and B Recommendations (2026); Guidelines for Vaccinating Pregnant Persons (2026) **S**
- Nausea and vomiting, step by step: small frequent dry meals, fluids between meals, ginger if she wishes, and avoiding smells that trigger nausea; doxylamine-pyridoxine from today, raised to four tablets a day if needed; then a second drug (metoclopramide, promethazine, or ondansetron after counseling); PUQE-24 score, weight, pulse, blood pressure, and electrolytes at each visit; same-day review if she cannot keep fluids down for 24 hours or loses more than 5 percent of her pre-pregnancy weight. Guideline: ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (2018); The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69) (2024) **S**
- Maternal-fetal medicine consultation for a first pregnancy at 38 with moderate nausea and vomiting and early weight loss: escalation thresholds, aneuploidy screening and diagnostic options, preeclampsia prevention, tuberculosis risk, and the plan for the rest of the pregnancy. Guideline: ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (2018); The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69) (2024); Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020); Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021) **S**
- Aneuploidy screening offered to all, with diagnostic testing available: cell-free DNA from 10 weeks, a nuchal translucency scan at 11 to 14 weeks, or chorionic villus sampling or amniocentesis; a detailed anatomy scan at 18 to 22 weeks. Guideline: Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020) **S**
- Tuberculosis screening with an interferon-gamma release assay because of tuberculosis deaths in her household; a shielded chest radiograph and treatment decisions only if it is positive. Guideline: Latent Tuberculosis Infection in Adults: Screening (2023) **S**
- Mental health: PHQ-9 at intake and the EPDS in each trimester and after any admission, with support for the strain of severe vomiting and for anxiety rooted in family loss. Guideline: Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum (Clinical Practice Guideline No. 4) (2023); Perinatal Depression: Preventive Interventions (2019) **S**
- Preeclampsia prevention: low-dose aspirin 81 mg at bedtime from 12 to 16 weeks until delivery if she has one high-risk or more than one moderate-risk factor (she has two: first pregnancy and age 35 or older); blood pressure at every visit. Guideline: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021) **S**
- Monitoring while nausea and vomiting last: PUQE-24, weight, pulse, and blood pressure at every visit; electrolytes until stable on oral intake; liver tests if abnormal; mood each trimester; antiemetic side effects (drowsiness, restlessness or abnormal movements, constipation, palpitations). Guideline: ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (2018); The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69) (2024) **S**

## Guideline basis

- ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (2018), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69) (2024), Royal College of Obstetricians and Gynaecologists (BJOG)
- Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021), U.S. Preventive Services Task Force
- Latent Tuberculosis Infection in Adults: Screening (2023), U.S. Preventive Services Task Force
- Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum (Clinical Practice Guideline No. 4) (2023), American College of Obstetricians and Gynecologists
- Perinatal Depression: Preventive Interventions (2019), U.S. Preventive Services Task Force
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Guidelines for Vaccinating Pregnant Persons (2026), Centers for Disease Control and Prevention
